Omega Healthcare Investors appoints Matthew P. Gourmand as President and CEO effective October 1, 2026
Effective October 1, 2026, Omega Healthcare Investors' Board appointed Matthew P. Gourmand, the company's President since January 1, 2025, to serve as President and Chief Executive Officer, succeeding C. Taylor Pickett upon Mr. Pickett's retirement. The Board also appointed Mr. Gourmand as a director to fill the vacancy created by Mr. Pickett's retirement from the Board for the remaining term expiring in 2027. Mr. Pickett's retirement is not the result of any disagreement with the company on operations, policies...
Key takeaways
CEO succession effective October 1, 2026: Matthew P. Gourmand appointed President and CEO, succeeding C. Taylor Pickett upon his retirement.
Internal promotion providing continuity: Gourmand has served as OHI's President since January 1, 2025.
Board appointment: Gourmand was appointed to the Board to fill Mr. Pickett's vacancy for the term expiring in 2027, with Board size unchanged at eight directors.
Clean transition: The 8-K explicitly states Mr. Pickett's retirement is not the result of any disagreement with the company on operations, policies, or practices.
No related-party transactions or third-party arrangements were disclosed in connection with the appointment.
No new compensation terms disclosed: Gourmand will not receive separate compensation for his director service beyond his existing employment agreement, and no committee assignments are planned.
Filing type: Item 5.02 Form 8-K filed October 1, 2026.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow OHI in real time
Get material earnings, filing, IR, and earnings-call alerts by email.